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Type 2 diabetes, which accounts for the vast majority of diabetes worldwide is the result of a 
lowered sensitivity of the insulin receptors, resulting in impaired sugar metabolism is and 
chronic hyperglycaemia. There is no cure for type 2 diabetes, though some people with pre-
diabetes and diabetes manage to reach and hold normal blood sugar levels, thus avoiding 
most of the complications that come with chronic hyperglycaemia; this is sometimes referred 
to as ‘reversing diabetes’. A healthy diet, with sufficient amounts of fruits, nuts, and 
vegetables is positively correlated with maintaining glycaemic control and prevention of 
diabetes-related complications.  
Whereas many different dietary phytochemicals have been considered to play a role in the 
glycaemic control and in prevention of degenerative diseases, there is currently no consensus 
on a particular mode of action. In this review, a range of pre-clinical studies and intervention 
studies, including randomised double-blind, placebo controlled clinical studies, are 
considered that investigate the role of dietary compounds in the prevention of type 2 diabetes-
related complications. Three generic mechanisms of action can be discerned: compounds that 
reduce sugar uptake, compounds that restore insulin function, and compounds that attenuate 
the effects of oxidative stress and chronic inflammation. Particularly the latter has received 
wide attention in the form of activation of the Nrf2-antioxidant response element signalling 
pathway by various polyphenolic or triterpenoid compounds. Although individual reports 
may present models with clear looking signalling cascades, an overall review shows that 
many biologically active compounds in the human diet are pan assay interference substances 
that alter several cell functions simultaneously, which makes them less attractive for drug 
development. 
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Diabetes is a metabolic disorder characterised by prolonged high blood sugar levels 
(hyperglycaemia). Assessment of blood sugar levels is typically done by measuring the level 
of glucose in small blood samples after overnight fasting (fasting blood sugar); levels less 
than 100mg/dL (5.6mM) are considered healthy, 100-125mg/dL (5.6-6.9mM) is considered 
pre-diabetes, and more than 126mg/dL (>7mM) is considered diabetes.  
In 2019, 351.7 million people of working age (20–64 years) had diagnosed or undiagnosed 
diabetes. This number is expected to rise to 417.3 million by 2030. The largest increase is 
expected to take place in the regions where economies are moving from low- to middle-
income status (Williams et al., 2019) 
Type 2 diabetes (T2D), which accounts for the vast majority (around 90%) of diabetes 
worldwide (Williams et al., 2019), is the result of a lowered sensitivity of the insulin 
receptors notably on cells in the liver and muscles. The insulin resistance is often initially 
compensated by β-cell hypersecretion of insulin (hyperinsulinaemia); prescription drugs like 
sulfonylureas work by stimulating β-cells to more activity. However, in advanced stages the 
β-cells, located in the islets of Langerhans of the pancreas, eventually are no longer able to 
secrete enough insulin (hypoinsulinaemia). Abnormal insulin sensitivity commonly precedes 
the clinical diagnosis of diabetes by up to 15 years (Zaccardi et al. 2015).  
Insulin signalling pathways are triggered by the binding of insulin to the transmembrane 
insulin receptor. This induces auto‐phosphorylation in tyrosine residues of the receptor 
followed by downstream cascading events which create a suitable binding site for insulin 
receptor substrate proteins (IRSs), which is then activated via phosphorylation by different 
insulin‐induced kinases such as PKC, SIK2, AKT, S6K1, mTOR, ERK1/2, and ROCK1.  
Insulin‐independent kinases, such as AMPK and GSK3, in turn phosphorylate IRSs and 




resistance is unclear, defects in insulin signal transduction play a prominent role (Yaribeygi et 
al., 2018). The biguanide metformin (1) (Fig. 1) is commonly prescribed to delay the loss of 
insulin sensitivity in the liver, muscle, and adipose tissue, but the exact molecular mechanism 
of this drug is not yet completely understood. Metformin is an analogue of galegine (2), a 
naturally occurring guanidine found in Galega officinalis L. which was also used to treat 
diabetes but is now considered obsolete (Bailey & Day, 2004). 
 
Fig 1: Compounds with known antidiabetic activity  
 
Diabetes is linked with roughly doubling the risk for a wide range of vascular diseases, and 
data based on a study with 302 430 participants are consistent with a causal association, 
although the causal component or components in this pathway have not yet been identified 
(Sarwar et al., 2010, Sarwar & Danesh, 2010). Diabetes is also associated with premature 
death from infectious diseases, several types of cancer, and degenerative disorders. However, 




biologic factors such as insulin resistance or hyperinsulinemia, or due to shared risk factors 
(e.g., obesity) or a combination of these (Seshasai et al., 2011). 
 
Fig 2: Formation of Advance Glycation Endproducts (AGEs) 
 
Chronic hyperglycaemia can result in a number of complications. High levels of glucose or 
fructose in the blood plasma can initially result in glycation reaction, i.e. nonenzymatic 
attachment of a monosaccharide to the N-terminus of a protein or to the amino groups of 
arginine or lysine residues followed by Amadori rearrangement resulting in the formation of 
a ketoamine (Fig. 2). Glycation should not be confused with glycosylation, the enzyme-
controlled post-transcriptional process that occurs during synthesis of glycoproteins as part of 
normal healthy physiology. Glycation occurs continuously over the lifetime of the protein, so 
the concentration of glycated haemoglobin (HbA1c) levels can be used as a measure of the 




measure for blood glucose management, and can be tested every three months – a normal 
HbA1c target is below 48mmol/mol (or 6.5% on the older measurement scale). People who 
are at risk of hypoglycemia, or for whom tight blood glucose regulation is not advised, may 
be advised to keep their HbA1c below 59 mmols/mol (under 7.5% in the old percentage 
units). 
After the initiation phase of glycation, a propagation phase starts where Amadori products are 
degraded resulting in the formation of free radicals and reactive dicarbonyl species, e.g. 3-
deoxyglucosone. Additional reactive dicarbonyls, e.g. methylglyoxal which is formed as by 
product of glycolysis, also add to the propagation of glycation. Finally, in the advanced 
phase, advanced glycation products (AGEs) are formed, and the interaction between AGEs 
and their receptor, RAGE, is considered to be a main cause of chronic diseases, oxidative 
stress, and a state of low-grade chronic inflammation (Brownlee 2001; Peyroux & Sternberg, 
2006; Yeh et al., 2017a, 2017b; Fournet et al., 2018). During normal metabolism, 
methylglyoxal and other reactive aldehydes are detoxified by the glyoxalase system, but 
chronic hyperglycaemia can eventually overwhelm this detoxification process, resulting in 
the accumulation of AGEs. 
Interaction of AGEs with RAGE on the membrane of cells such as macrophages, mesangial 
or endothelial cells, pericytes, causes intracellular oxidative stress and activation of nuclear 




Role of diet 
Occurrence of T2D is correlated with lifestyle and dietary patterns; notably, greater 




2013). Although currently there is no cure for T2D, some people with pre-diabetes and 
diabetes manage to reach and hold normal blood sugar levels, and thus avoid most of the 
complications that come with prolonged hyperglycaemia; this is sometimes referred to as 
‘reversing diabetes’. For overweight or obese individuals with T2D, a weight loss of at least 
5% was shown to improve circulating glucose and lipid levels over 12 months (Franz et al., 
2015). A 3-year randomized clinical trial followed by 7-years of open-label modified 
intervention follow-up showed that regular moderate exercise and a healthy diet over a 10-
year period reduced the absolute risk of getting diabetes by 25.9% (Herman et al., 2013). 
Systematic reviews and meta-analyses of dietary patterns have indicated that regular 
consumption of red meat, processed meat, and sugar-sweetened beverages is linked with an 
increased incidence of T2D, whereas increased consumption o whole grains, fruits, and dairy 
is linked with a lowered risk of becoming diabetic (Medina-Remón et al., 2017; 
Schwingshackl et al., 2017). 
Diabetes is a chronic condition, and it takes continuous effort to attain adequate glycemic 
control amongst diabetic patients. Individuals with T2D are commonly treated with multiple-
medication regimens - some to achieve glycemic control, others to treat diabetic 
complications - to an average of four prescription medications per patient per day.  In 
addition, weight loss is often advised in management of T2D (Gonzalez et al., 2016). 
Diabetes places a significant self-management burden on affected individuals and families, 
but available evidence suggests that diabetes among the illnesses with the lowest levels of 
adequate self-management, especially for regimen aspects involving lifestyle change. Non-
adherence to prescription medicines is common, and patients often look to alternative forms 
of therapy such as herbal medicines (Ezuruike & Prieto, 2014). Meta analyses of the use of 
herbal medicines to manage T2D, e.g. berberine (3) from Coptis chinensis Franch 




L.) as in Asia, Brazil, and east Africa, have indicated some efficacy, although authors warn 
for the risk of bias in the included studies (Lan et al., 2015; Peter et al., 2019). More 
methodologically sound large controlled trials, using standardized preparations, are required 
to more clearly quantify the therapeutic effect of herbal preparations. 
 
 
Mechanism studies  
There is a general consensus that a diet rich in fruit, vegetables, and high in fibre is beneficial 
for maintaining blood sugar levels within reasonable limits, and for slowing down or averting 
diabetes-related complications. However, there is no canonical vision on any particular 
dietary compounds that can be considered the main active pharmaceutical ingredient. Neither 
is there a consensus on any one particular mechanism of action. Rather three generic 
mechanisms of action can be discerned: compounds that reduce sugar uptake, compounds 
that restore insulin function, and compounds that attenuate the effects of oxidative stress and 
chronic inflammation.  
The prescription drug acarbose (4) (Glucobay™, Precose™, Prandase™) prevents hydrolysis 
of starches into glucose. Similarly, several dietary flavonoids (5) (Fig. 3) also effectively 
inhibit the activity of α-amylase and α-glucosidase (Xiao et al., 2013a,b; Zhu et al., 2020). 
Acarbose causes adverse effects such as bloating, flatulence, or diarrhoea, and this is often 
used as a justification to look for natural alternatives. However, arguably any compound that 
inhibits degradation of complex carbohydrates will result in delivery of these carbohydrates 
to the colon where they are digested by bacteria, causing gastrointestinal side-effects. Papers 
on α-amylase and α-glucosidase inhibitors tend to report results of in vitro enzyme inhibition 
assays - sometimes backed up by in silico docking studies, but often omit data on in vivo 





Fig. 3: Inhibitors of carbohydrate digestion and glucose absorption 
 
or phytate (6), normally present in the aleurone layer of cereals though often lost in the 
milling process, hinders digestion by binding with starch and starch-associated protein 
(Biskup et al., 2017). Some simple phenolics, e.g. chlorogenic acid (7) and ferulic acid (8) 
have exhibited the ability to block glucose transporter SGLT1, and thus inhibit glucose 
absorption from the small intestine and glucose reabsorption in the kidneys (Biskup et al., 
2017). 
The isoflavone genistein (9) (Fig. 4) enhanced activity of adenylate cyclase activity in a dose-
dependent way (10nM - 5 µM) in insulin-secreting murine cell lines INS-1 and MIN6 and in 
vitro cultured mouse pancreatic islets. The resulting rise in intracellular cAMP activated 
protein kinase A, and overall led to an insulinotropic effect (Liu et al., 2006). Studies on in 
vitro grown cell cultures (human HepG2 liver carcinoma and 3T3-L1 murine adipocytes) 





Fig. 4: Compounds that can restore activity of the insulin receptor 
 
can restore activity of the insulin receptor (IR), and trigger phosphorylation of insulin 
receptor substrate (IRS) resulting in the activation of the PI3K/Akt2 signalling pathway 
which simultaneously decreases gluconeogenesis and increases glucose uptake by 
translocating the glucose transporter 4 (GLUT-4) from intracellular stores to the plasma 
membrane. The results of in vitro studies were confirmed in in vivo studies with 
streptozotocin (STZ)-induced diabetic rats and mice (Hajiaghaalipour et al., 2015). 
The ability of phytochemicals to inhibit AGEs formation is commonly measured using a 
relatively simple in vitro assay in which bovine serum albumin (BSA) is incubated with 
glucose or fructose for several days to let glycation proceed, either in the presence or absence 
of inhibitors (MacPherson et al., 1988; Kim & Kim, 2003). After separation of the proteins 




spectrometry or by more advanced analytical techniques such as GC-MS, HPLC, ELISA, 
western blotting, or immunohistochemistry. The effect of several glycation inhibitors has also 
been established in vivo, using STZ-induced diabetic rats and mice (Xie & Chen, 2013). 
Vitamin B derivatives pyridoxamine (13) and benfotiamine (14) (Fig. 5), and the antioxidant 
vitamins C (15) and E (16) showed promising AGE inhibiting activity in preclinical studies, 
though clinical trials have been rather disappointing so far (Peyroux & Sternberg, 2006). A 
wide range of flavonoids has been tested for the AGEs inhibiting activity, and a structure-
activity comparison indicated that particularly C3-methoxylated flavone aglycones (17) show 
a good promise (Xie & Chen, 2013). 
 
Fig. 5: Inhibitors of AGE formation 
 
The activation of pro-inflammatory signalling pathways by AGEs (Yeh et al., 2017a) can be 




transcription factor Nrf2. Best known as the transcription factor reducing oxidative stress, 
Nrf2 is now recognized for alleviating various causes of stress including xenobiotics, 
excessive nutrient /metabolite supply, inflammation or accumulation of misfolded proteins. 
Several modes of Nrf2 activation by phytochemicals have excellently reviewed recently 
(Matzinger et al., 2018). Most Nrf2-activators have been identified using mammalian in vitro 
cell cultures. Prominent phytochemical activators of Nrf2-signalling (Fig. 6) include  
 
Fig. 6: Activators of Nrf2 
 
resveratrol (18), flavonoids - e.g. apigenin (19), luteolin (20), rutin (21), and catechins (11, 
12), and other natural compound groups e.g. cinnamic aldehyde (22), curcumin (23), 
sulforaphane (Matzinger et al., 2018). In a similar fashion, palmitate-induced activation of 
pro-inflammatory signalling pathways in human aortic endothelial cells (HAECs) could be 
reversed. This time, anthocyanins (10) themselves had little effect, but anthocyanin-derived 




that are known to circulate in humans following blueberry consumption (Bharat et al., 2017). 
Relief of inflammation and oxidative stress is believed to allow partial restoration of the β-
cells in the islets of Langerhans, and may thus indirectly contribute to increased insulin 
production and consequently to improved glucose homeostasis. In addition, reduction in 




In most in vitro bio-assays discussed so far, variable dietary phytochemicals were tested 
either as aglycones or as the naturally occurring glycosides. The assay results do not 
necessarily reflect what happens in vivo, because the compounds that are active in the target 
tissues (e.g. liver, pancreas, kidneys, adipose tissue) are metabolites of the dietary compounds 
in the form of glutathione, sufate, or glucuronate conjugates. Of all the naturally occurring 
glycosides, only glucosides are hydrolysed in the small intestine and subsequently absorbed 
as aglycones. After absorption, the aglycones are rapidly reconjugated and enter plasma and 
the circulatory system; a substantial part of the conjugated molecules is taken out the 
circulatory system in the liver as then returned into the digestive tract with bile. Other 
naturally occurring glycosides (e.g. galactosides, rhamnosides, rutinosides) are not absorbed 
at all, and in an unaltered state enter the large intestine where they are degraded by the 
intestinal microflora. The bacterial degradation products of dietary compounds are finally 
absorbed at the very distal end of the human digestive tract. These are the compounds that are 
ultimately available to assert their activity in the various target tissues, e.g. blueberry 
anthocyanins malvidin-3-glucoside (25) and cyanidin-3-glucoside (26) are broken down into 




sulfate (29), vanillic acid-4-sulfate (30), and isovanillic acid-3-sulfate (31) (Fig. 7) (Bharat et 
al., 2017).  
 
Fig. 7: Anthocyanidins and their metabolites can induce relief of inflammation and oxidative 
stress 
 
For anthocyanins and other bioactive compounds in food, there is a high inter and intra-
individual variation in the response to intake, and a variation in gut microbiota, that in many 
cases leads to contradictory results in human trials (Eker et al., 2020). In addition, 
hyperglycaemia, or complications linked with hyperglycaemia, are known to affect 
bioavailability of phytochemicals (Chen et al., 2017; Wang et al., 2012; Xiao and Högger, 
2014; Xie et al., 2012). The understanding on how diabetic condition impacts on the 
bioavailability of polyphenols is very limited and mainly derives from in vitro and animal 
studies. The altered pharmacokinetics of polyphenols in diabetics is partly attributed to 
diabetes-associated malfunctions of liver and/or kidney characterised by modified intestinal 
β-glucuronidase activity and altered expression of metabolic enzymes as compared to non-




microbiota may further add to the complexity of diabetic influences on the metabolism of 
polyphenols (Deng et al., 2007; Deng et al., 2008). Hyperglycaemia in diabetics also affects 
polyphenols’ interactions with plasma proteins. Glucose competes with polyphenols for 
binding to plasma proteins (Wang et al., 2012; Du et al., 2013), and the glycated plasma 
proteins have weakened non-covalent interaction affinities for dietary phytochemicals (Xie et 
al., 2012). T2D plasma proteins were found to have up to 10 times lower affinities for 
polyphenols than healthy human plasma proteins (Xie et al., 2012). Moreover, polyphenols in 
the blood of diabetics are more inclined to interact with free radicals in plasma. As a 
consequence, the delivery of polyphenols to other tissues is affected which limits the 
exploitation of their antioxidant potential (Cao et al. 2015). 
 
 
Human intervention studies 
Studies using whole food - berries 
Evidence on effects of consumption of fresh berries on management of the diabetic condition 
in humans is scarce. One study found that an acute oral dose of 40 g of sweetened dried 
cranberries (Vaccinium macrocarpon Aiton) to T2D adults, in 4 hours resulted in a decreased 
postprandial level of blood glucose compared to the group fed with an equicaloric amount of 
white bread (Wilson, 2010). Similar effects on diabetic control have been reported when 
using processed forms of berries including (freeze) dried, frozen and juiced. Dried 
cranberries, when taken at 40 g with a high-fat fast-food-style breakfast in an acute setting by 
T2D patients, led to significant reductions of 16% and 14% in postprandial glucose at 2h and 
4h respectively (Schell et al., 2017). The study intervention groups also experienced 
decreased levels of inflammatory and oxidative stress markers, i.e. interleukin 18 (IL-18) and 




Table 1: Human intervention studies investigating effects of whole food consumption on diabetic and inflammatory markers, antioxidant status and vascular 
endothelial function in T2D patients 
Intervention 
group 







55g raw cranberrry (RC), 40 g 
sweetened dried cranberries (SDC), 40 g 
reduced-sugar dried cranberries (RSDC), 
57 g white bread (WB); once 
Persisted plasma glucose elevation in WB 
comparing to other groups.    Insulin AUC values 
for RC and RSDC lower than WB or SDC.               
Plasma insulin for RSDC lower at 60 min than 
either WB or SDC. 








40 g dried cranberries (DC) with high-
fat-fast-food-style breakfast (974 kcal), 
80 g banana; once  
Decreased plasma glucose at 2h and 4h in DC 
versus banana group. 






Phase I: 250 g frozen raspberries (FR), 
85 g ripe banana (RB); once.                       
Phase II:  250 g FR, 85 g RB; daily for 4 
weeks 
Phase I: In FR, lower levels of serum glucose at 2 
and 4 h postprandial versus control group;  levels 
of inflammatory markers IL-6 and hsTNF-α were 
also lower at 4 h postprandial in FR versus RB.                        
Phase II: continued lowering effects of FR on 
lowering IL-6 and hsTNF-α levels versus RB. 
Schell et al. (2019) 
36 unmedicated 






50 g freeze-dried strawberries (FDS), 
macronutrient matched placebo powder 
with strawberry flavour (PP); daily for 6 
weeks 
FDS decreased C-reactive protein levels as a 
biomarker of inflammation and lipid peroxidation 
in the form of MDA (lipid peroxidation marker) at 
6 weeks versus PP. FDS led to a reduction of 
HbA1c levels and an increase in total antioxidant 
status versus PP.  
Moazen et al. (2013) 
58 T2D patients Randomised, 
double-blind,  
parallel-arm, 
controlled study  
1 cup (240 ml) Cranberry juice (CJ), 240 
mL placebo drink (natural mineral water 
with strawberry flavour) (PD); daily for 
12 weeks 
At 12 weeks, decreased levels of serum glucose 
and apo B and increased levels of serum apo A-1 
and Paraoxonase-1 (PON-1) activity in CJ 
compared to their initial values and also with PD.  






200 mL barberry juice (BJ), control with 
no intervention; daily for 8 weeks 
After intervention, SBP, DBP, FBS, TC and TG 
levels decreased and PON-1 as an antioxidant 
enzyme increased in BJ versus control. 




10 T2D patients 
for feasibility 








FS: cocoa drinks containing 75 mg, 371 
mg or 963 mg of flavanols; once.                              
ES: 3 doses of cocoa drink (CD-ES) 
containing 321 mg flavanols per dose 
daily; 30 days. 
FS: A single ingestion of flavanol-containing 
cocoa was dose-dependently associated with 
significant acute increases in circulating flavanols 
and flow-mediated dilation (FMD) of the brachial 
artery assessed as the vascular function.                                                                             
ES: CD-ES consumption increased baseline FMD 
by 30% , the acute increases of FMD continued to 
be manifest throughout the study.  
Balzer et al. (2008) 




13.5 g high-polyphenol (PL) chocolate 
(containing 3.5% PL) (HPC), 13.5 g 
low-PL chocolate containing 0.9% PL 
(LPC); once 
Improvement in endothelial function and 
decreased oxidative stress measured as the level 
of urinary 15-F2t-isoprostane in HPC versus LPC. 







25 mL / day extra-virgin olive oil 
(EVOO) containing 577 mg of phenolic 
compounds / kg; 4 weeks  
Reduced levels of fasting plasma glucose, HbA1c, 
aspartate aminotransferase, alanine 
aminotransferase and visfatin as well as reduced 
BMI and body weight in EVOO  
Santangelo et al. 
(2016) 
80 T2D patients  Randomised, 
double-blind, 
controlled study 
226.8 mg Brazilian green propolis 
(BGP), the placebo; daily for 8 weeks  
Values of blood uric acid and estimated 
glomerular filtration rate in patients taking the 
placebo became worse at 8 weeks compared to the 
baseline, yet this did not occur in patients 
consuming BGP. 







effects of berry consumption still remain to be tested in an appropriate study setting. Frozen 
raspberries (Rubus idaeus L.) also show positive impacts on diabetic conditions. An acute 
feed of frozen raspberries yielded significantly lower levels of blood glucose and 
inflammatory markers, including IL-6 and high-sensitivity tumour necrosis factor alpha 
(hsTNF-α), within 4h of postprandial phase. These anti-inflammatory effects of raspberries 
persisted throughout a continued 4-week supplementation (Schell et al., 2019). In another 
case, strawberries (Fragaria x ananassa Duchesne) in their freeze-dried form taken as a 50 g 
dose (equiv. to 500 g of fresh strawberries) significantly improved both inflammatory and 
antioxidant status of subjects with T2D, as indicated by decreased C-reactive protein and 
lipid peroxidation product levels respectively, after a 6-week supplementation (Moazen et al. 
2013). In addition, the intervention also led to a significant reduction in HbA1C, the marker 
for monitoring of glycemic management (Tanaka et al., 2011). The observed benefits of 
berries and their processed products in diabetic management are ascribed to their 
phytochemical content, predominantly anthocyanins (USDA, 2014). The clinical evidence 
indicates that these flavonoids have potential as adjuvants for the amelioration of diabetic 
conditions. When consumed in juice form, berries still deliver anti-diabetic effects in T2D 
adults. In a 12-week randomised and controlled trial, T2D patients who consumed one-cup 
(240 mL) of cranberry juice daily had decreased levels of fasting blood glucose at week 12 
(Shidfar et al., 2012b). Similar results were reported in a barberry (Berberis vulgaris L.) juice 
study, where a daily dose of 200 mL for 8 weeks significantly improved the systolic and 
diastolic blood pressure, fasting blood sugar as well as blood lipid profiles, including total 





Table 2: Human intervention studies investigating effects of tea consumption on diabetic and inflammatory markers, weight status and vascular function in 
T2D patients 
Intervention group Study design Dose; duration Study outcomes (significant) Reference 
16 obese, insulin-




100 ml black tea (BT), 100 mL 
beetroot juice (BJ), 100 mL control 
(water); once 
BT decreased vascular resistance (VR) 
compared to control in conduit, resistance 
and micro-vessels. BJ decreased 
postprandial VR in resistance vessels, but 
not in conduit artery and micro-vessels. 
Postprandial insulin response was 
attenuated by ~29 % after tea, but not 
beetroot juice. 
Fuchs et al. (2016) 
50 T2D patients Randomised, 
double-blind, 
controlled study 
3 cups (600 mL) Diabetea teaTM  
extract (DT),                                                                           
3 cups (600 mL) placebo extract (PL); 
daily for 12 weeks 
DT suppressed CD4+ T cell expression of 
IL-1 beta and IL-8 and up-regulated the 
expression of IL-10 and the Treg/IL-17 
ratio. A significant decrease in HbA1c 
and LDL was observed at the end of the 
study period in DT.  
Mahmoud et al. 
(2016) 
16 T2D patients Randomised, 
controlled, cross-
over study 
6 g Gynostemma pentaphyllum (GP) 
tea, 6 g placebo green tea (PGT); daily 
for 4 weeks 
The FBG and steady-state plasma glucose 
were lower after GP treatment compared 
to PGT treatment. The levels of FPG in 
PGT group were slightly reduced to 0.2 
+/- 1.5 versus 1.9 +/- 1.0 mmol/L in GP 
group. 









controlled study  
Green tea containing 582.8 mg of 
catechins (catechin group), green tea 
containing 96.3 mg of catechins 
(control group); daily for 12 weeks.  
The decrease in waist circumference was 
greater in the catechin group versus 
control group. Adiponectin, which is 
negatively correlated with visceral 
adiposity, increased only in the catechin 
group. The increase in plasma insulin 
(Ins)at week 12 was greater in the 
catechin group than in the control group. 
In patients treated with insulinotropic 
agents, the increase in insulin levels was 
observed only in the catechin group, and 
the decrease in HbA1c at week 12 was 
greater in the catechin group than in the 
control group.  
Nagao et al. 2009 
63 T2D patients Randomized, 
parallel, controlled 
study 
4 cups of green tea (4C), 2 cups of 
green tea (2C), no green tea (0C); daily 
for two months.  
4C had a decrease in body weight, BMI, 
waist circumference, and SBP.  
Mousavi et al. 2013 
55 T2D patients  Randomised, 
crossover, 
controlled study  
9g green tea contained in 900 mL 
water, control; daily for 4 weeks. 
Inflammatory markers, such as hsCRP 
and IL-6, blood glucose, lipid profiles, 
insulin resistance, serum adiponectin 
levels, brachial-ankle pulse wave velocity 
were unchanged after green tea 
consumption. 




100 T2D patients Randomized, 
parallel study 
150 mL Sour tea (ST),  150 mL green 
tea (GT); three times a day for 4 
weeks. 
HDL-c increased in both groups. The 
median of FBI in GT showed a decrease 
unlike the ST which showed an increase. 
The median of HOMA-IR after the 
intervention in GT showed lower levels 
than the ST. The median of b% only in ST 
showed increase after the intervention. 
The mean of S% only in ST showed a 
decrease after the intervention.  
Mozaffari-Khosravi 






Further studies using whole food - Cocoa-beans, virgin olive oil, propolis 
Cocoa (Theobroma cacao L.) -based food products have been found owning therapeutic 
potential in reducing the risk of vascular dysfunction among medicated diabetic patients. An 
acute consumption of cocoa powder-formulated drinks rich in flavanols, predominantly 
epicatechins (11-12), caused a significant improvement in the vascular endothelial function of 
medicated T2D patients (Balzer et al., 2008). The effects went in a dose-dependent manner 
when cocoa drinks containing flavanol contents of 75 mg, 371 mg and 963 mg were applied 
sequentially to the patients on 3 separate occasions (Balzer et al., 2008). The cardioprotective 
benefits of the cocoa drinks were also testified at a flavanol content level of 321 mg per dose 
in a 30-day intervention with 3 doses ingested daily, following the acute study (Balzer et al., 
2008). Similar acute effects of cocoa on vascular endothelial health were manifested in the 
form of high-polyphenol contained (3.5% w/w) chocolate after a 2h consumption among T2D 
patients with or without medication. In addition, the protective role of the flavanol-rich 
chocolate against the acute hyperglycaemia-induced oxidative stress were also shown in 
those patients (Mellor et al., 2012). Epicatechins (11-12), as the predominant form of 
polyphenols found in cocoa-based food and beverages, have been suggested be responsible 
for the anti-diabetic outcomes, due to their known properties of improving the serum 
antioxidative status and increasing nitric oxide levels via its modulation on nitric oxide 
synthase (Hollman et al., 2011). Periodic hyperglycaemia as a common feature of diabetes 
can cause an increased level of oxidative stress, which can then deteriorate the vascular 
endothelial functions (Brownlee, 2001). This may partly account how phytochemical 
antioxidants deliver merits to the anti-diabetic battles.  
Extra-virgin olive oil, pressed from the fruits of Olea europaea L., and commonly consumed 
as part of the Mediterranean diet, has drawn considerable interest for its benefits in 




Table 3: Human intervention studies investigating effects of fruit extract consumption on diabetic markers and antioxidant status in T2D patients 
Intervention group Study design Dose; duration Study outcomes (significant) Reference 








A capsule of 350 mg whortleberry fruit 
extract, placebo; every 8h for 2 months 
The extract lowered the levels of FBG, 2-
h postprandial glucose, and HbA1c (p = 
0.007, p 0.05) versus placebo after the 
intervention. 
Kianbakht et al. 
2013 
13 T2D patients  Randomised, double-
blind, controlled 
study 
1 mg Berberis fruit extract (BFE), 
placebo; twice daily for 2 months 
BFE had a reduction in serum glucose and 
HbA1c levels during the 8 weeks of study. 
Moazezi & Qujeq 
(2014) 
31 T2D patients Randomised, double-
blind, controlled 
study 
3 g/d Berberis vulgaris fruit extract 
(BVFE), placebo; 3 months 
There were decreases in serum TG, TC, 
LDL-c, apo B, glucose, and insulin and a 
significant increase in TAC at the end of 
the study in BVFE versus placebo. There 
were differences in serum TG, TC, LDL-
c, apoB, glucose, insulin, TAC, and 
insulin resistance  between the two groups 
at the end of the study. 
Shidfar et al. 
(2012a) 
60 T2D patients  Randomised, double-
blind, controlled 
study 
A capsule of Cornus mas L. fruit extract 
(FE) containing 150 mg anthocyanins; 
placebo; 2 capsules twice daily for 6 
weeks 
The insulin level increased while the 
HbA1C and TG levels decresaed in FE 
versus placebo.  
Soltani et al. 
(2015)  
8 male T2D patients Randomised, 
crossover, acute, 
controlled study 
0.47 g standardised bilberry extract (BE) 
(36 % (w/w) anthocyanins) which 
equates to about 50 g of fresh bilberries, 
placebo; once 
BE had a significant decrease in the 
incremental AUC for both glucose and 
insulin versus placebo.  









375 mg capsule containing 150 mg of 
green tea catechins (equivalent to the 
amount in 7 cups of green tea) and 75 
mg of black tea theaflavins (equivalent 
to the amount in 35 cups of black tea), 
375 mg capsule of cellulose; daily for 3 
months 
The changes in glycosylated hemoglobin 
were not significantly different between 
study arms. No hypoglycemic effect of 
extract of green or black tea was found. 






showed significantly improved glycaemic control status, body mass index (BMI) and 
circulating profile of inflammatory adipocytokines after a daily consumption of high-
polyphenol extra virgin olive oil containing 577 mg of phenolic compounds/kg (Santangelo et 
al., 2016).  
Another type of food, Brazilian green propolis which is less commonly consumed compared 
to the foods aforementioned, was studied in an 8-week feeding trial. T2D adults who received 
226.8 mg/day of the propolis did not show significant improvement of the hyperglycaemic 
state, but the treatment prevented a reduction of glomerular filtration rate and concomitant 
build-up of uric acid that is commonly seen in T2D patients (Fukuda et al., 2015). 
 
Beverage consumption - Black tea 
In addition to fruit juice, several research studies paid attention to tea (Camellia sinensis (L.) 
Kuntze), one of the most commonly consumed beverages in the world, and regarded its anti-
diabetic functions. Ingestion of 100 mL of flavonoid-rich black tea resulted in decreased 
peripheral vascular resistance (VR) and an attenuation of postprandial insulin response by 
approximately 29% among a group of obese and insulin-resistant male adults within 3h after 
consumption (Fuchs et al., 2016). Beet juice, pressed from the taproot of Beta vulgaris L., is 
rich in nitrate and a dietary source of nitric oxide (Lundberg et al., 2006), was tested in the 
same study group at a level of 100 mL, but exerted less modulating impact on the 
postprandial skeletal blood flow and glucose homeostasis compared to black tea. It indicated 
that the effects of black tea may be ascribed to its flavonoid content that has the potential of 
improving vascular endothelial functions (Ras et al., 2011), which can then stimulate the 
postprandial blood flow responses (Fuchs et al., 2016). The anti-diabetic efficacy of black tea 
was also examined when taken in a mixed formula with other types of medicinal plants. 




Table 4: Human intervention studies investigating effects of the consumption of herb and spice extract on diabetic and inflammatory markers and antioxidant 
status in T2D patients 
Intervention group Study design Dose; duration Study outcomes (significant data) Reference 
19 well-controlled T2D 
patients 
Randomised, double-
blind, crossover, acute, 
controlled study 
A capsule of 6 g Panax ginseng, 
placebo (vanilla-flavoured 
capsulated corn starch); daily for 
12 weeks  
Decreased 75 g-OGTT-PG indices, fasting-
PI and 75 g-OGTT-PI indices, and 
increased fasting-ISI (HOMA) and 75 g-
OGTT-ISI versus placebo. 
Vuksan et al. 2008 
20 T2D patients Randomised, 
crossover, controlled 
study 
2.2 g Panax ginseng root in 
capsules, placebo; daily for 4 
weeks  
Great decrease in HOMA-IR after ginseng 
intervention. Lower fasting plasma glucose 
in ginseng group versus placebo group. 
Ma et al. 2008 
9 T2D patients Randomised, 
controlled study 
3-g American Ginseng (AG) 
capsules, placebo; once  
Differences found in postprandial glycaemia 
between AG and placebo when capsules 
were taken 40 min before or together with 
25 g oral glucose challenge 
Vuksan et al. 2000a 
10 T2D patients Randomised, acute, 
controlled study 
3, 6, or 9 g ground American 
Ginseng (AG) root in capsules, 0 g 
(placebo); once 
Treatment (0, 3, 6, and 9 g AG) affected 
postprandial glycaemia. compared with 0 g 
(placebo). Either dose of AG reduced AUC 
and incremental glycemia at 30 min, 45 min 
and 120 min respectively. 
Vuksan et al. 2000b 
41 T2D patients Randomized, double-
blind, placebo-
controlled 
2 g/day of ginger powder (GP) 
supplement, lactose as placebo 
(LP); 12 weeks 
Reduced levels of FBG, HbA1c, apo B, apo 
B/apo A-I and MDA in GP after 
intervention in comparison to their baseline 
and LP. The level of apolipoprotein A-I 
increased in GP. 





88 T2D patients Randomized, double-
blind, placebo-
controlled study 
3 one-gram capsules containing 
ginger powder (GP), 3 one-gram 
control capsules; daily for 8 weeks 
FBG mean showed a decrease in ginger, 
whereas control had an increase. Similar 
variation found in HbA1c. Differences 
found in the median of fasting insulin level, 
IS% and HOMA-IR between GP and 
control before and after the intervention. 
QUICKI mean increased more in GP after 
intervention versus control. 
Mozaffari-Khosravi et 
al. (2014b) 
204 T2D patients Randomized, single-
blind, parallel, 
controlled study 
3 g ginger dried powder (GDP), 
control; daily for 8 weeks 
GDP had beneficial effects on TC, LDL, 
and HDL levels versus control. 
Azimi et al. (2014) 
40 T2D patients Randomized, double-
blind, placebo-
controlled study 
3 g of Momordica charantia fruit 
and seed extract in capsules, 
placebo; 3 months 
No significant change in HbA1c or FBG 
values. 
Dans et al. (2007) 
51 T2D patients Randomized, double-
blind, placebo-
controlled study 
6 g of Momordica charantia fruit 
and seed extract in capsules, 
placebo; 1 month 
No significant change in HbA1c or FBG 
values. 
John et al. (2003) 
51 T2D patients Randomized, placebo-
controlled study 
1, 3, or 6 g cinnamon daily, 
respectively, placebo; 40 days 
All three levels of cinnamon reduced the 
mean FBG, TG, LDL and TC levels 
Khan et al. (2003) 
79 T2D patients Randomized, double-
blind, placebo-
controlled study 
3 g a cinnamon extract powder 
(CE), a placebo capsule (PC); 
three times a day for 4 months  
Higher reduction of FBG in CE than PC 
between pre- and post-intervention 
Mang et al. (2006) 
42 T2D patients Randomized, double-
blind, placebo-
controlled study 
500 mg cinnamon (C. cassia) in a 
capsule, 500 mg placebo (wheat 
flour) in a capsule; twice daily for 
3 months 
No significant differences between the 
cinnamon and placebo groups in the change 
in any measure of FBG, TC, LDL, HDL, 
TG and insulin levels from baseline to 3 
months 
Blevins et al. (2007) 
204 T2D patients Randomized, single-
blind, parallel, 
controlled study 
3 g cinnamon dried powder 
(CDP), control; daily for 8 weeks 
CDP had beneficial effects on TC, LDL, 
and HDL levels versus control. 








2 g turmeric supplements (TS); 
control with no treatment; daily 
for 4 weeks 
Decreased FBG and HbA1c levels, an 
reduction in MDA and hsCRP 
(inflammatory marker) levels, and enhanced 
total antioxidant status in TS versus control. 
TS had improved lipid metabolism shown in 
the levels of LDL, non-HDL cholesterol and 
LDL/HDL ratio. 
Maithili Karpaga Selvi 





the remaining comprising 12 other ground dried medicinal herbs, was given to medicated 
T2D patients at a daily dose of 3 cups (equiv. 7.5g dry tea) for a period of 12 weeks 
(Mahmoud et al., 2016). Positive results were seen as a significant reduction of the 
concentration of HbA1c and low-density lipoprotein (LDL), and also a suppression of 
inflammatory markers among patients. It was suggested that flavonoids, triterpenes and 
phytosterol contents contribute to the anti-diabetic properties of the tea. Another type of 
herbal tea called Jiaogulan (Gynostemma pentaphyllum Thunb.) tea demonstrated a capacity 
of reducing the fasting plasma glucose level and improving the insulin sensitivity in T2D 
patients when consumed at 6 g daily for 4 weeks (Huyen et al., 2013). Jiaogulan is a wild 
herb native to China and Vietnam, where it has been widely used as a medicinal herb for 
prevention and amelioration of diabetes. The potential of glycaemic control of this herb in 
T2D, is suggested be attributed to its dammarane-type triterpenoids (32) (Fig. 8) (Huyen et 
al., 2010; Huyen et al., 2012). To date, limited studies have examined the effects of green tea 
in diabetic management, yet study outcomes appear to be mixed in the current evidence. In 
the study on the Jiaogulan herbal tea (Huyen et al., 2013), green tea (Camellia sinensis (L.) 
Kunze) was used as the placebo consumed at a dose of 6 g for 4 weeks. However, the latter 
exerted fewer effects on the fasting blood glucose status and also yielded a lower level of 
insulin sensitivity measured by the values of the steady-state-plasma. In a study among T2D 
patients, a six-fold increment in the ingestion dose of catechins (11-12) (from 96.3 mg to 
582.8 mg daily) delivered as green tea led to significantly greater reductions in both waist 
circumference and HbA1c levels after a 12-week intervention, with the latter effect only 
found in patients receiving insulinotropic agents (Nagao et al. 2009). In general, there was no 





Fig. 8: Phytochemicals from cornelian cherry (Cornus spec.), ginseng and ginger can restore 
glucose homeostasis 
 
only significant increases in serum insulin and adiponectin that is negatively linked to 
visceral adiposity were observed in the higher-catechin-dosed group only (Nagao et al., 
2009). This represents the potential of using green tea as an agent for HbA1c-control and 
weight management for T2D patients. The benefits of green tea on weight control was also 
found among T2D patients when ingested with four cups of green tea (prepared using 2.5 g 
tea bags in 200 mL of boiling water) for a period of 2 months. In addition, a reduction in 
systolic blood pressure also appeared post intervention. However, no effects were detected on 
glucose metabolic and oxidative stress markers (Mousavi et al., 2013). Catechins were 
suggested the main player for improving the anthropometric measures of patients (Nagao et 
al., 2007; Chantre et al., 2002). Similarly, green tea seemed to be ineffective in modulating 
the inflammatory status and arterial stiffness among T2D participants after their consumption 




when compared to sour tea (Hibiscus sabdariffa L.), showed a better outcome in lowering the 
level of insulin resistance measured by homeostasis model assessment of insulin resistance 
among T2D patients at an ingested dose of 3g / tea bag in 150 mL of hot water for 3 times a 
day over 4 weeks (Mozaffari-Khosravi et al. 2014). Based on the evidence above, the anti-
diabetic effect of green tea remains inconclusive and requires further exploration.  
 
Plant food extracts 
The antidiabetic effects of phytochemicals are not limited to whole foods, but also evidenced 
in studies using fruit extracts as the intervention foods. Caucasian whortleberry (Vaccinium 
arctostaphylos L.) was examined in an intervention study testing its efficacy of glycaemic 
control in T2D patients who were resistant to conventional anti-hyperglycaemic drugs 
(Kianbakht et al. 2013). 350 mg of the whortleberry fruit hydroalcoholic extract was 
delivered in a form of capsule containing excipient weighted at 19.2% w/w to patients for 
every 8h for 2 months in combination with anti-hyperglycaemic drugs. The result was a 
significant reduction of fasting blood glucose, 2h-postprandial glucose and HbA1c levels in 
patients. The safety of its consumption was also testified. Thus, whortleberry fruits were 
shown to exert safe and beneficial effects in enhancing glycaemic control to a greater extent 
than using anti-hyperglycaemic drugs solely in diabetic patients (Kianbakht et al. 2013). 
Anthocyanins (10) were supposed to account for the anti-glycaemic action (Kianbakht et al. 
2013). Apart from anthocyanins, whortleberries are also known to contain chlorogenic acid 
(7) (Abidov et al. 2006) and myricetin (33) (Fig. 8) (Ayaz et al. 2005), which might 
potentially contribute to the glycaemic control capacity of the fruits (van Dijk et al. 2009; 
Ong et al. 2000). In a study of the similar research setting involving T2D patients who went 
on a 2-month intervention with 1 mg of barberry (Berberis fruit) extract supplementation 




exhibited noticeable effects on glucose metabolism regulation in patients who experienced 
significantly reduced serum glucose and HbA1c levels post intervention (Moazezi and Qujeq, 
2014). Besides, Shidfar et al. (2012a) also revealed the potential of barberry extract on 
improving blood lipid profile favourable to cardiovascular health, enhancing the Total 
Antioxidant Capacity and improving the glucose metabolism of T2D patients using a higher 
dose at 3 g/d for a duration of 3 months (Shidfar et al. 2012a). The mechanism for those 
observed effects was suggested be ascribed to the anti-diabetic actions of berberine (3) which 
is the main active alkaloid found in barberry at a content level of 5.2-7.7% (Shidfar et al., 
2012a). This notion is also supported by studies using berberine (3) on its own ingested at a 
dose of 500 mg 2-3 times a day for 12-13 weeks among newly diagnosed T2D patients (Yin 
et al. 2008; Dange et al. 2016). Both studies confirmed the positive modulating effect of 
berberine (3) on glucose and lipid metabolism in patients, which was comparable to that of 
metformin (1). The observed benefits may be attributed to the induction of glycolysis 
pathway and/or inhibition of the glucosidase enzymes acted by berberine (3), as previously 
suggested by (Yin et al. 2008; Zhang et al. 2008). Another rich source of anthocyanins (10), 
cornelian cherry (Cornus mas L.) extract, was tested on 60 T2D patients that took 2 capsules 
twice daily for 6 weeks, with each capsule containing 150 mg of anthocyanins (10). The 
intervention yielded improvements in glycaemic control reflected by increased insulin level 
and decreased levels of HbA1c and plasma triglycerides (Soltani et al., 2015). Anthocyanin 
contents of the fruit may be accountable for the observed effects, based on the previous in 
vitro (Jayaprakasam et al. 2005) and animal studies (Jayaprakasam et al. 2006). In addition, 
the triterpenoids ursolic acid (34) (Zhang et al. 2006) and oleanolic acid (35) (Fig. 8) (Hsu et 
al. 2006), present in the fruit have been given the merit for possibly playing a role in patient’s 
glucose homeostasis together with anthocyanins (10). Anti-diabetic properties of plant fruit 




as the test food was given to individual T2D patients at a dose of 0.47 g (36% w/w 
anthocyanins (10), equating to about 50 g of fresh bilberries) contained in a single capsule 
(Hoggard et al. 2013). Mixed results were obtained including significant improvements in 
postprandial glycaemic response at 120, 150 and 180 minutes post consumption, and no 
changes were found in examined markers of inflammation and oxidation during the period of 
300 min after dosage (Hoggard et al. 2013). The positive impact on lowering glycaemic 
response may be linked to the actions of the anthocyanin (10) contents of the fruit (Cai et al. 
2011), typically cyanidin-3-galactoside (26) (Adisakwattana et al. 2009) and oligomeric 
procyanidins (Schäfer and Högger, 2007; Kumar et al. 2011). Those bioactive components 
have shown the potency of reducing the breakdown of carbohydrates via their inhibitory 
actions on α-glucosidase in vitro (Adisakwattana et al. 2009; Schäfer and Högger, 2007).  
In contrast to the intervention trials with tea as a beverage (Fuchs et al., 2016), capsules with 
dried standardised tea extract did not show convincing results in T2D patients (Mackenzie et 
al. 2007). A mixture of decaffeinated green tea and black tea extract was ingested at two 
different doses (375 mg and 750 mg in a capsule per day) with each arm lasting for 3 months 
among T2D patients, 80% of whom being on hypoglycaemic medication. Despite the 
concentrated polyphenol content of the test capsules, i.e. the 375 mg capsule was constituted 
of 150 mg of green tea catechins (equating to 7 cups of green tea) and 75 mg of black tea 
theaflavins (equating to 35 cups of black tea), the glycaemic responses between the test foods 
and placebo formula did not vary significantly among patients after the intervention 
(Mackenzie et al. 2007).  
 
Medicinal herbs and spices in a powder form 
Apart from the approach of using whole-foods, their extract or beverages, phytochemicals are 




American ginseng (Panax quinquefolius L.) and Asian ginseng (Panax ginseng C.A Meyer), 
has attracted emerging interest for its glycaemic control potency for T2D. Panax ginseng, 
when dosed as capsules at a daily intake level of 6 g per T2D patient for 12 weeks, delivered 
favourable effects in glycaemic control regarding modulation of plasma glucose and insulin 
levels for healthy T2D patients. Still, HbA1c level remained unchanged throughout the 
intervention (Vuksan et al., 2008). The hypoglycaemic and insulin-sensitising effect of Panax 
ginseng was preserved when the ingestion dose dropped to around 2.2 g per day for a shorter 
intervention period of 4 weeks among well-controlled T2D patients by either habitual diet or 
hypoglycaemic agents (Ma et al. 2008). Yet, although insulin resistance decreased 
significantly compared to that observed in the placebo group, the plasma insulin levels 
remained unaffected, which contrasted with results of a previous study (Vuksan et al., 2008). 
No effects were shown on oxidative stress and antioxidant capacity markers either (Ma et al., 
2008), which might be due to the low level of antioxidant capacity of the supplement used 
(Ma et al., 2008), as compared to that of other plant foods, i.e. fruits and vegetables and teas 
when using the same assessment technique, i.e. FRAP assay (Szeto et al., 2002). The active 
components of ginseng, i.e. ginsenosides - glycosides of dammarane triterpenoids (32), were 
hypothesised to be accountable for the anti-diabetic effects of ginseng supplementation 
(Sievenpiper et al., 2004). However, due to the large variability among ginsenoside 
composition of ginseng (Vuksan et al., 2008) and the unknown bioactivity profile of the 
individual ginsenosides, the mechanistic basis for the clinical observations remains as yet 
unclear. Two acute intervention studies found that ground American ginseng, when given as 
a 3g-capsule per person, T2D patients experienced significant reductions in postprandial 
glycaemia, with the reduction of incremental glycaemia occurring as early as 30 min post-
consumption as compared to the placebo group (Vuksan et al., 2000a, b). Again, the 




patients, but other bioactive components of ginseng including polysaccharides (ginsenans) 
and peptidoglycan (panaxans) may also contribute to the global effects of ginseng (Attele et 
al. 1999). Enhancement of nitric oxide synthesis via the action of ginsenosides (Gillis, 1997) 
is regarded as one of the plausible mechanistic explanations for the improved insulin 
sensitivity and carbohydrate metabolism resulted from ginseng supplementation (Roy et al. 
1998; Spinas et al. 1998).  
Ginger (Zingiber officinale Roscoe), as another type of herbal plant, has shown positive 
effects on regulating glucose homeostasis, improving blood lipid profile and enhancing 
antioxidant capacity when delivered as ground rhizome powders to T2D patients (Khandouzi 
et al. 2015; Mozaffari-Khosravi et al. 2014b; Azimi et al. 2014). The tested doses used 
ranged from 2 g to 3 g per day over an intervention period of 8 or 12 weeks among T2D 
patients. The reported beneficial effects of ginger supplementation may be attributed to its 
bioactive and also antioxidant components typically gingerol (36), shogaol (37) and paradol 
(38) (Fig. 8) (Fuhrman et al. 2000; Lebda et al. 2012). In contrast, a similar dose of bitter 
melon (Momordica charantia L.) fruit and extract ingested to T2D patients at a dose of 3 g or 
6 g for either 3 months or 1 month respectively has not given any significant changes in 
markers of glycaemic control, yet, no side effects were documented (Dans et al. 2007; John et 
al. 2003). Other common spices have been looked at in studies recruiting different 
intervention settings. Cinnamon (Cinnamomum verum J.Presl.) bark has exerted some extent 
of glycaemic control in T2D patients with moderate effects shown on fasting blood glucose 
level only, yet evidence has been mixed among studies using different doses (1g, 3g or 6g) 
and durations of intervention (40 days, 8 weeks, 4 months or 3 months), as well as recruiting 
T2D patients at various diabetic management status (Khan et al. 2003; Mang et al. 2006; 
Blevins et al. 2007; Azimi et al. 2014). Similarly, cinnamon (3g/day), cardamom (Elettaria 




Table 5: Key phytochemicals mentioned in the literature, their modes of action and molecular targets 
Compound class Modes of antidiabetic actions Molecular target Type of 
study 
Reference 
Catechins Modulate glucose absorption 
and uptake, reduce glycaemia. 
Reduce lipid absorption, 
regulate lipid profile. Improve 
insulin resistance.  
Pancreatic α-glucosidase, α-amylase 
and maltase, Na+-dependent glucose 
transporter (SGLT1), AMPK 
activation. Bile acid metabolism and 
lipogenesis in hepatic cells. JNK-
activated signalling pathway, 






Kim et al., 2013;  
Kobayashi et al.,2000; 
Li et al., 2018a;  
Li et al., 2018b 
Mi et al., 2018.  
Shimizu et al., 2000;  
Solinas & Becattini, 2016; 
Tsuneki et al., 2004;  
Ueda et al., 2010;  
Zhong et al., 2006.   
Anthocyanidins Inhibition of oxidative stress 
and reduce blood glucose. 
Improve insulin resistance, 
regulate blood lipid profile. 
Stimulate insulin secretion. 
Endogenous antioxidant enzymes and 
islet β cells. Adipocytes, insulin 
pathway activation via FoxO1, TNF-α. 
Expression of intracellular 
Ca2+ signalling pathway and glucose 
transport-related gene (Glut2), DPPIV 
and its substrate GLP-1, mRNA 





Roy et al., 2008;  
Tsuda et al., 1999;  
Zhu et al., 2012;  
Yan & Zheng, 2017. 
Takikawa et al., 2010;  
Guo et al., 2012.  
Sun et al., 2018;  
Johnson & Mejia, 2016. 
Proanthocyanidins  Reducing carbohydrate 
digestion, modulating hepatic 
glucose metabolism. Modulate 
Pancreatic β-cell functions. 
Protecting 
against diabetic neuropathy.  
α-glycosidase. Hepatic glucokinase 
activity, phosphoenolpyruvate 
carboxykinase, activation of AMPK 
and PI3K/Akt pathways to decrease 
glucose-6-phosphatase, insulin 
signalling pathways. Oxidative stress, 
insulin secretion and β-cell survival. 
Endoplasmic reticulum (ER) stress 




Johnson, et al., 2013;  
Lee, et al., 2007;  
Schafer & Hogger, 2007; 
Zhang et al., 2009;  
Bang & Choung, 2014; 
Cordero-Herrera, et al., 2013; 
Kurimoto et al., 2013;  
Yang & Chan, 2017.  
Ding et al., 2014 ;  




Procyanidins Reduce blood glucose and 
macronutrient digestion. 
Improve insulin sensitivity, 
insulin resistance and hepatic 
gluconeogenesis. Promote 
glucose homeostasis. Prevent 
β-cell dysfunction. 
Liver lipogenesis, insulin and AMPK 
signalling pathways' activation for 
inducing the translocation of GLUT4 
in skeletal muscle, intestinal amylases, 
proteases and lipases. Pro-
inflammatory cytokine expression, 
hepatic inflammation suppression, 
lipid depot in the adipose tissue and 
liver. Islet β cell apoptosis prevention, 
Pdx1 and Glut2 mRNA expression, 
and antioxidant levels in pancreatic 




Cremonini, et al., 2016; 
Baiges et al., 2010;  
Lu et al., 2011;  
Chen et al., 2012; 
Ahangarpour et al., 2016; 
Yamashita et al., 2016; 
Vazquez-Flores et al., 2018. 
Stilbenoids Modulate hepatic glucose 
metabolism. Improve glucose 
homeostasis. Promote glucose 
uptake and intracellular 
transport. Prevent insulin 
resistance. Enhance β-cell 
function and insulin secretion. 
Antioxidant defence 
enhancement in pancreatic 
tissue.  
Modulation of glucose and glycogen 
metabolism enzymes. Glycogen 
synthase activation and glycogen 
phosphorylase inhibition, reduced 
expression of transcription factor NF-
κB and pro-inflammatory cytokines 
(IL-1β and IL-6) in liver. Increased 
number of glucose transporter GLUT4 
and its translocation to plasma 
membrane of myocyte via PI3K-Akt 
pathway. Fatty acid oxidation 
promotion, and decreased activity of 
glucokinase in skeletal muscle. 
Caspase-3 inhibition for preventing β-
cell apoptosis. Activity of antioxidant 
enzymes (CAT, SOD, GPx, and 




Palsamy & Subramanian, 
2009;  
Andrade et al., 2014;  
Do et al., 2012;  
Deng et al., 2008;  
Tan et al., 2012;  
Chi et al., 2007;  
Goh et al., 2014;  
Chen et al., 2011;  





Tannins Delay intestional glucose 
digestion and absorption, and 
reduce blood glucose level. 
Upregulate glucose transport. 
Decreased oxidative stress in 
pancreatic β cells, and α-amylase and 
α-glucosidase inhibition. Stimulated 
phosphorylation of protein factors in 
the insulin-mediated glucose transport 
pathway.   




Serrano et al., 2009;  
Hosoyama et al., 2003;  
Zhang & Kashket, 1998;  
Kato et al., 2017;  
Matsui et al., 2007;  
Gin et al., 1999;  
Liu et al., 2005;   
Curcumin Hypoglycaemic effect, protect 
β-cell, decrease insulin 
resistance, regluate lipid 
metabolism 
Mitigated ER stress and oxidative 
stress via activated Nrf2-Keap1 
antioxidant response, decreased 
adipogenesis and enhanced catabolism 
of adipotic tissues, AMPK activation 
and upregulation of fibroblast growth 
factor 21 (FGF21) amount and/or 
action.  




Jin et al., 2018;  
Pivari et al., 2019;  
Rashid et al., 2017; 
Zha et al., 2018) 
Hydroxycinnamic 
acids 
Reduce blood glucose level, 
improve insulin resistance, 
increase insulin secretion and 
sensitivity, improve β-cell 
function. 
Increased glukinase activity, and 
decreased glucose-6-phosphatase and 
phosphoenolpyruvate carboxykinase 
activities in liver; modulation of 
glucose metabolism enzymes, AMP-
activated protein kinase activation, 
inhibition of adipogenesis and 
gluconeogenesis, protection against 
glucolipotoxicity-mediated oxidative 
stress and inflammation.  
In vitro,  
animal 
studies 
Kasetti et al., 2012;  
Jung et al., 2007;  
Ohnishi et al., 2004; 
 Son et al., 2011;  
Pei et al., 2016;  





 (1g/day) did not exert demonstratable impacts on glycaemic control, inflammatory markers 
or oxidative stress among T2D patients after daily ingestion for 8 weeks (Azimi et al. 2014). 
In contrast, daily consumption of 2g dried and powdered rhizomes of turmeric (Curcuma 
longa L.) for 4 weeks resulted in reduced levels of fasting blood glucose and HbA1c, 
improved lipid profile and enhanced antioxidant status in T2D patients (Maithili Karpaga 





The clinical evidence included in this review sheds light on the potential benefits of using 
certain types of plant-based whole foods or their extracts as a nutritional or therapeutic 
measure in ameliorating diabetic conditions and preventing the disease advancement among 
T2D patients. In addition to the discussed mechanisms of actions of phytochemicals on 
diabetic conditions, an emerging notion related to phytochemicals’ interactions on the 
Nuclear factor erythroid 2-related factor 2 (NrF2) has added values to further understanding 
the mechanistic basis of phytochemicals’ roles in dietary management of chronic diseases.  
Recent evidence has unveiled Nrf2’s regulatory role in cellular resistance to oxidants. Acting 
as a transcription factor, it mediates the redox disturbances induced by environmental or 
endogenous factors through modulating the expression of multiple antioxidant response 
element (MRE)-dependent genes (Ma, 2013). Besides, Nrf2 is anti-inflammatory and its 
deficiency results in inflammation in an experimental setting (Johnson et al., 2010; 
Rangasamy et al., 2004, 2005; Garbin et al., 2009; Cho et al., 2004; He & Ma, 2012). This 
may be explained by the observed inhibitory actions of Nrf2 on the NF-κB pathway and 




research is still largely required to understand the exact anti-inflammatory mechanisms of 
Nrf2.  
The phytochemicals that are considered to exert activity related to management of glycaemic 
control, or to prevention of diabetes-related complication, do so by acting on a variety of 
cellular targets and their effect often refers to transcription factors that are nodes in multiple 
signalling pathways. Polyphenolic flavonoids (notably EGGC) are prominently present in the 
literature on biologically active compounds with antidiabetic activity, as are berberine, and 
curcumin; in the context of drug discovery, all these compounds would be dismissed as pan 
assay interference substances (PAINS) (Baell & Walters, 2014; Baell 2016). Although 
individual reports may present models with clear looking signalling cascades, an overall 
review shows that PAINS alter numerous cell functions. Currently, there is little consensus 
and the mechanisms underlying antidiabetic activity are poorly understood. Arguably, many 
biologically active dietary products may act via rather non-specific mechanism like 
membrane bilayer perturbation (Ingólfsson et al., 2014). These properties make the listed 
biologically active dietary phytochemicals unattractive objects for drug discovery programs. 
However, they can still explain the mode of action of many dietary compounds in the 
prevention of diabetes-related complications or of degenerative diseases. Repeated low level 
activation of anti-inflammatory responses may be sufficient to maintain cellular homeostasis 
by avoiding peaks and troughs, e.g. by reducing post-prandial peaks in glucose levels and 
concomitant oxidative stress. In this view, ameliorating dietary compounds will never have 
the strength of therapeutic drugs like the sulfonylureas or metformin, and are not likely either 
to be lead-compounds for development of novel therapeutic drugs. However, dietary 
phytochemicals may exert a mild activity, enough to ‘nudge’ cells and tissues back to a 
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